Bart S. Hendriks
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
- Oncology 32
- HER2/EGFR in Cancer Research 18
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 6
-
- Cancer therapeutics and mechanisms 9
- Glycosylation and Glycoproteins Research 5
- Co-authors
- Douglas A. Lauffenburger (12 shared papers)H Wiley (4 shared papers)Thomas J. Wickham (19 shared papers)Elena Geretti (16 shared papers)Lee K. Opresko (2 shared papers)Shannon C. Leonard (13 shared papers)Helen Lee (17 shared papers)Daniel F. Gaddy (13 shared papers)
- Journals
- Cancer Research (13 papers)Molecular Cancer Therapeutics (4 papers)British Journal of Cancer (3 papers)Theranostics (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Bart S. Hendriks
62 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 121
- Biomaterials 728
- Oncology 734
- Radiology, Nuclear Medicine and Imaging 529
- Molecular Biology 1.1k
- Pharmacology 120
Countries citing papers authored by Bart S. Hendriks
This map shows the geographic impact of Bart S. Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart S. Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart S. Hendriks more than expected).
Fields of papers citing papers by Bart S. Hendriks
This network shows the impact of papers produced by Bart S. Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart S. Hendriks. The network helps show where Bart S. Hendriks may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart S. Hendriks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 311 | |
| 2 | 2003 | 158 | |
| 3 | 2017 | 145 | |
| 4 | Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. | 2003 | 118 |
| 5 | 2009 | 116 | |
| 6 | 2018 | 107 | |
| 7 | 2016 | 103 | |
| 8 | 2006 | 100 | |
| 9 | 2012 | 99 | |
| 10 | 2021 | 93 | |
| 11 | 2008 | 77 | |
| 12 | 2013 | 73 | |
| 13 | 2004 | 65 | |
| 14 | 2012 | 60 | |
| 15 | 2021 | 58 | |
| 16 | 2018 | 58 | |
| 17 | 2003 | 56 | |
| 18 | 2013 | 55 | |
| 19 | 2015 | 54 | |
| 20 | 2018 | 51 |
About Bart S. Hendriks
Bart S. Hendriks is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biomaterials and Computational Theory and Mathematics, having authored 65 papers that have together received 2.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Nanoparticle-Based Drug Delivery (12 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Cancer therapeutics and mechanisms (9 papers), Lung Cancer Research Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Biomaterials (728 citations), Oncology (734 citations), Radiology, Nuclear Medicine and Imaging (529 citations), Molecular Biology (1.1k citations) and Pharmacology (120 citations). Bart S. Hendriks has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Douglas A. Lauffenburger, H Wiley, Thomas J. Wickham, Elena Geretti, Lee K. Opresko, Shannon C. Leonard, Helen Lee, Daniel F. Gaddy, Christopher W. Espelin and David de Graaf. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, British Journal of Cancer, Theranostics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.